Literature Cited
P. H. Abrams, P. J. R. Sha, R. Stone and R. G. Choa, Br. J. Urol.,54, 527 (1982).
H. G. Baumgarten, B. Flack, and A. F. Holstein, Z. Zellforsch.,90, 81 (1968).
C. R. Bouffioux and L. Renders, Eur. Urol.,10, 306 (1984).
M. Caine, S. Raz, and M. Zeigler, Br. J. Urol.,47, 193 (1985).
M. Caine, S. Perlberg, and S. Meretyk, Br. J. Urol.,50, 551 (1978).
J. A. Gosling and S. A. Thompson, Urol. Int.,32, 269 (1977).
H. Hedlund and K.-E. Anderson, J. Urol. (Baltimore),130, 275 (1983).
A. Shapiro, B. Mazouz, and M. Caine, Urol. Res.,9 17 (1981).
Additional information
Laboratory of Pharmacology, S. Ordzhonikidze All-Union Pharmaceutical Chemical Research Institute, Moscow. Department of Urology, I. M. Sechenov First Moscow Medical Institute. Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 106, No. 8, pp. 187–188, August, 1988.
Rights and permissions
About this article
Cite this article
Kaminka, M.É., Zhirnikova, M.L., Vinarov, A.Z. et al. Effect of prazocin on tissue of the human prostate with benign hypertrophy. Bull Exp Biol Med 106, 1129–1130 (1988). https://doi.org/10.1007/BF00840378
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00840378